Intas becomes India’s first company to launch Romiplostim to treat chronic ITP

Drug-maker Intas Pharmaceuticals Ltd has become the first company to launch Romiplostim in India under the brand name Romy for the treatment of chronic Immune Thrombocytopenia (ITP). ITP is an autoimmune blood disorder which leads to low platelet counts. The ..

Jan Aushadhi Stores

The Jan Aushadi Kendras were established under the Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP) campaign to provide the generic drugs which cost less but are the equivalent in quality and effectiveness of expensive branded drugs. The PMBJP was launched by ..

Short Note – Indian Medical Council (Amendment) Bill

The lower house of the Indian Parliament, the Lok Sabha passed the Indian Medical Council (Amendment), Bill. The bill will now be tabled in the Rajya Sabha for discussion and voting. The bill was passed in the Lok Sabha by ..

UP government launches Dastak campaign against AES & JE disease

The Uttar Pradesh government has launched massive door to door campaign “DASTAK” against Acute Encephellitis Syndrome (AES) and Japanese Encephallitis (JE) disease. The campaign, which was launched in association with UNICEF, will run from 1st to 31st July. Under this ..

Short Note – Rare Diseases

A disease can be defined as a disorder in the structure/function of a living organism that is not the result of a past injury. What are rare diseases? Conventionally, a rare disease is one which affects only a small population ..

India signs loan agreement with World Bank to eliminate TB

India has signed a loan agreement worth $400 million with the World Bank (WB) to help treat and eliminate Tuberculosis from the country. In India, around five lakh people died every year due to Tuberculosis. According to Finance Ministry, the ..